Drug intelligence / Profile preview

palladin small interfering RNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intranasal, Intratumoral, Subcutaneous, Topical, Inhalation, Ophthalmic, Intrathecal, Endoscopic Injection, Intramuscular, Intradermal
01

Overview

Palladin small interfering RNA (siRNA) is a sequence-specific RNA interference (RNAi) agent designed to silence the expression of the PALLD gene. Palladin is a cytoskeletal protein that plays a critical role in actin bundle assembly, cell adhesion, and motility. In various cancers, including prostate adenocarcinoma, PALLD is often upregulated and associated with tumor progression, migration, and mitophagy-related pathways. By utilizing the RNA-induced silencing complex (RISC) to target and degrade PALLD mRNA, this siRNA inhibits the proliferation and colony-forming ability of cancer cells. While primarily used as a research tool for functional genomics and target validation, it represents a potential therapeutic modality for treating advanced or metastatic cancers where Palladin expression is a driver of disease progression.

Other names
PALLD siRNAPalladin siRNAsiRNA targeting PALLDsiRNA targeting Palladin
02

Targets

PALLD (Palladin, cytoskeletal associated protein)

Beyond the preview

Go deeper on palladin small interfering RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on palladin small interfering RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call